Effects of the D-1 agonist SKF-38393 combined with haloperidol in schizophrenic patients

Arch Gen Psychiatry. 1990 Feb;47(2):190-1. doi: 10.1001/archpsyc.1990.01810140090014.
No abstract available

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine / therapeutic use*
  • Adult
  • Clinical Trials as Topic
  • Drug Therapy, Combination
  • Haloperidol / therapeutic use*
  • Humans
  • Male
  • Placebos
  • Psychiatric Status Rating Scales
  • Schizophrenia / drug therapy*
  • Schizophrenic Psychology

Substances

  • Placebos
  • 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine
  • Haloperidol